My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.
June 28, 2000
New York, June 28, 2000 (Praxis Press) Interstitial lung disease is a major cause of death in patients with systemic sclerosis (scleroderma). Studies have not precisely evaluated the association between alveolitis and lung fibrosis, and the subsequent deterioration of pulmonary function. A recent retrospective cohort study compared the outcomes of three patient groups with scleroderma lung disease: patients without alveolitis, and alveolitis patients with and without cyclophosphamide treatment a